
Rodrigo Bagur
Dr. Rodrigo Bagur is an interventional cardiologist, clinician-scientist, and cardiovascular epidemiologist. He is a Professor with the Departments of Medicine and of Epidemiology and Biostatistics at Schulich Medicine & Dentistry and is co-director of Western’s Heart & Brain Trials Unit. His research focuses on improving outcomes for patients with coronary artery and structural heart disease, from diagnosis to long-term management. He leads the OPTICS (Optimizing Patient Trajectories to Improve Cardiovascular outcomes through Science) program, which identifies steps in cardiovascular care pathways that can be simplified without compromising safety. Among others, his most recent works include the DAYLIGHT trial; the largest individual-patient-data meta-analysis of sex-specific outcomes after transcatheter aortic valve implantation (481,353 patients); the OPTICS-CAD study of a CT-first coronary assessment strategy before valve implantation; and the provincial OPTICS-STEMI study of early-discharge pathways after STEMI. A dedicated practitioner, researcher, and educator, Dr. Bagur has authored nearly 300 peer-reviewed publications and has supervised more than 40 trainees, all of whom have published peer-reviewed work. Dr. Bagur comes to this Clinical Trials Leadership Program as an experienced investigator who leads a stablished research program. Pursuing this program reflects his commitment to becoming a trial leader who contributes to the broader capacity for high-quality randomized evidence.















